P1450: VOXELOTOR TREATMENT LEADS TO IMPROVED VIABILITY OF SICKLE ERYTHROCYTES

por Konté, Kadère, Gaartman, Aafke, van Zwieten, Rob, Veldthuis, Martijn, van Bruggen, Robin, Biemond, Bart, Nur, Erfan
Publicado 2023

Vaso‐occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID‐19)

por Nur, Erfan, Gaartman, Aafke E., van Tuijn, Charlotte F. J., Tang, Man Wai, Biemond, Bart J.
Publicado 2020

Incentive spirometry to prevent acute chest syndrome in adults with sickle cell disease; a randomized controlled trial

por van Tuijn, Charlotte F.J., Gaartman, Aafke E., Nur, Erfan, Rijneveld, Anita W., Biemond, Bart J.
Publicado 2020

Fluid overload due to intravenous fluid therapy for vaso‐occlusive crisis in sickle cell disease: incidence and risk factors

por Gaartman, Aafke E., Sayedi, Ajab K., Gerritsma, Jorn J., de Back, Tim R., van Tuijn, Charlotte F., Tang, Man Wai, Heijboer, Harriët, de Heer, Koen, Biemond, Bart J., Nur, Erfan
Publicado 2021